Announcements Trials
Browse Landscape

Phase

Phase NA 57Phase 3 5Phase 2 2Phase 1 2Phase 4 1Phase 1/2 1

Status

Completed 19Active not recruiting 5Unknown 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Patient Compliance 1Neoplasm Metastasis 1Motor Activity 1Colorectal Neoplasms 1Cholangiocarcinoma 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Exercise × Clear all
NCT02162914 2020-07-31

REACHIN

Erasme University Hospital

Phase 2 Unknown
66 enrolled
Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

NCT01708824 2016-05-12

Diet and Physical Activity Intervention in CRC Survivors

The University of Hong Kong

Phase 2 Unknown
224 enrolled
Gastrointestinal

Motor Activity, Patient Compliance, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡